Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Ishikawa T, Shiratsuki S, Matsuda T, Iwamoto T, Takami T, Uchida K, Terai S, Yamasaki T, Sakaida I.

J Gastroenterol. 2014 Sep;49(9):1333-41. doi: 10.1007/s00535-013-0893-z.

PMID:
24096983
2.

Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.

Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M.

J Gastroenterol Hepatol. 2003 Aug;18(8):934-42.

PMID:
12859723
3.

Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.

Kumamoto M, Toyonaga A, Inoue H, Miyakoda K, Morita Y, Emori K, Sakamoto Y, Oho K, Sata M.

J Gastroenterol Hepatol. 2010 Jun;25(6):1129-35. doi: 10.1111/j.1440-1746.2010.06262.x.

PMID:
20594229
4.

Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.

Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H.

Intern Med. 2001 Aug;40(8):688-91.

5.

Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.

Su AP, Cao SS, Le Tian B, Da Zhang Z, Hu WM, Zhang Y, Wang ZL, Babu SR, Hu T.

Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):53-9. doi: 10.1016/j.clinre.2011.09.011.

PMID:
22099870
6.

Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.

Tanabe N, Ishii M, Sato Y, Akahane T, Kobayashi N, Gama H, Iwasaki T, Toyota T.

Dig Dis Sci. 2000 Mar;45(3):581-6.

PMID:
10749336
7.
8.

Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.

Inoue H, Emori K, Toyonaga A, Oho K, Kumamoto M, Haruta T, Mitsuyama K, Tsuruta O, Sata M.

Kurume Med J. 2014;61(1-2):1-8. doi: 10.2739/kurumemedj.MS63014.

9.

"Downgrading" of gastric varices with multiple collateral veins in balloon-occluded retrograde transvenous obliteration.

Fukuda T, Hirota S, Sugimoto K, Matsumoto S, Zamora CA, Sugimura K.

J Vasc Interv Radiol. 2005 Oct;16(10):1379-83.

PMID:
16221910
10.
11.

[Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in the treatment of gastric varices in cirrhotic patients with gastrorenal shunt].

Baik GH, Kim DJ, Lee HG, Min SK, Kong SJ, Kim JB, Lee JY, Hahn TH, Baek IH, Kim JH, Kim BS, Hwang WC.

Korean J Gastroenterol. 2004 Mar;43(3):196-203. Korean.

12.
13.

Balloon-occluded retrograde transvenous obliteration: one step beyond obliteration of gastric varices.

Kawanaka H.

J Gastroenterol Hepatol. 2012 Jan;27(1):3-4. doi: 10.1111/j.1440-1746.2011.06954.x. No abstract available.

PMID:
22188023
14.

Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein.

Furuichi Y, Moriyasu F, Sugimoto K, Taira J, Sano T, Miyata Y, Sofuni A, Itoi T, Nakamura I, Imai Y.

J Gastroenterol Hepatol. 2013 Sep;28(9):1526-31. doi: 10.1111/jgh.12234.

PMID:
23611144
15.

Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration.

Kasuga A, Mizumoto H, Matsutani S, Kobayashi A, Endo T, Ando T, Yukisawa S, Maruyama H, Yokosuka O.

J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):898-903. doi: 10.1007/s00534-010-0292-2.

PMID:
20461439
16.

Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation.

Nagao Y, Akahoshi T, Uehara H, Hashimoto N, Kinjo N, Kawanaka H, Tomikawa M, Uchiyama H, Yoshizumi T, Soejima Y, Shirabe K, Maehara Y.

Surg Today. 2014 Apr;44(4):633-9. doi: 10.1007/s00595-013-0535-3.

PMID:
23467977
17.

Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.

Mukund A, Rajesh S, Arora A, Patidar Y, Jain D, Sarin SK.

J Vasc Interv Radiol. 2012 Sep;23(9):1200-6. doi: 10.1016/j.jvir.2012.05.046.

PMID:
22832139
18.

The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications.

Saad WE, Kitanosono T, Koizumi J, Hirota S.

Tech Vasc Interv Radiol. 2013 Jun;16(2):101-51. doi: 10.1053/j.tvir.2013.02.003. Review.

PMID:
23830671
19.

[Balloon-occluded retrograde transvenous obliteration (B-RTO) for portal hypertension].

Hirota S, Fukuda T, Matsumoto S, Sugimoto K, Isaki K, Yoshikawa T, Akasaka Y, Sugimura K.

Nihon Igaku Hoshasen Gakkai Zasshi. 2000 Jun;60(7):361-7. Review. Japanese.

PMID:
10921294
20.

Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts.

Waguri N, Hayashi M, Yokoo T, Sato R, Arao Y, Setsu T, Sato M, Kohisa J, Hama I, Ohsugi K, Aiba T, Yoneyama O, Furukawa K, Sugimura K, Igarashi K, Suda T.

J Vasc Interv Radiol. 2012 May;23(5):650-7. doi: 10.1016/j.jvir.2012.01.065.

PMID:
22459878
Items per page

Supplemental Content

Support Center